Cargando…
Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generate...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/ https://www.ncbi.nlm.nih.gov/pubmed/32368862 http://dx.doi.org/10.1002/acm2.12881 |
_version_ | 1783563905245642752 |
---|---|
author | Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin |
author_facet | Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin |
author_sort | Laugeman, Eric |
collection | PubMed |
description | PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218. RESULTS: TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans. CONCLUSION: Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented. |
format | Online Article Text |
id | pubmed-7386180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73861802020-07-30 Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218. RESULTS: TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans. CONCLUSION: Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented. John Wiley and Sons Inc. 2020-05-05 /pmc/articles/PMC7386180/ /pubmed/32368862 http://dx.doi.org/10.1002/acm2.12881 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title_full | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title_fullStr | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title_full_unstemmed | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title_short | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
title_sort | comprehensive validation of halcyon 2.0 plans and the implementation of patient specific qa with multiple detector platforms |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/ https://www.ncbi.nlm.nih.gov/pubmed/32368862 http://dx.doi.org/10.1002/acm2.12881 |
work_keys_str_mv | AT laugemaneric comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT heermannana comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT hilliardjessica comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT wattsmichael comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT robersonmarshia comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT morrisrobert comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT goddusreekrishna comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT sethiabhishek comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT zoberiimran comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT kimhyun comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT muticsasa comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT hugogeoffrey comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms AT caibin comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms |